RHPN1 and hepatocellular carcinoma: While some of these predictions still require further validations, loss-of-function assays have confirmed that silencing of RHPN1-AS1 significantly impaired HCC proliferative ability and migratory ability, and we believe that our study could cast light on the exploration of potential prognostic markers for HCC.